10x Genomics CEO and leadership

Serge Saxonov is the founder and chief executive officer of 10X Genomics. Prior to that, he was the vice president for applications at QuantaLife. Saxonov holds a PhD in biomedical informatics from Stanford University. He has also studied applied mathematics at Harvard University. Saxonov lives in San Francisco, California, United States.

Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. Prior to 10x Genomics, Hindson was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad in 2011. From 2002 to 2008, he served in various positions of increasing responsibility at Lawrence Livermore National Laboratory, in the Chemical and Biological Weapons Non-proliferation Program. He has published extensively in his field and holds many patents for assays and instrumentation. Hindson earned his BSc in Chemistry in 1998 and his PhD in Chemistry in 2001 from Deakin University, Australia.

Justin McAnear is Chief Financial Officer at 10x Genomics, bringing over 20 years of financial and operational leadership experience in dynamic, high-growth environments that span the automotive, energy, tech, and healthcare sectors, along with service in the military. Prior to joining 10x, Justin was the Vice President of Worldwide Finance and Operations at Tesla for three years, where he helped scale the company through the Model X and Model 3 launches, SolarCity acquisition, and expansion into multiple foreign markets. Prior to that, Justin served as a Finance Director at Apple in Corporate FP&A and Worldwide Operations supporting Global Supply Chain and Logistics. Justin began his corporate finance career at Johnson & Johnson as a graduate of the J&J Finance MBA Leadership Development Program. During his time at J&J Justin held multiple roles supporting Global Supply Chain and Procurement, Global Transportation, Sales & Marketing, and Manufacturing. Justin served over nine years in the U.S. Navy as an aviator, and is a graduate of the U.S. Naval Academy in Annapolis, MD, where he earned his B.S. degree in Systems Engineering. He also holds an M.B.A. in Finance from the University of San Diego.

Ruth De Backer has served as Chief Business Officer of 10x Genomics since 2020, bringing extensive experience in strategy and corporate development in the pharma and medical industries to the company. Prior to 10x Genomics, Ruth spent nearly 20 years at McKinsey & Company and rose to partner where she led McKinsey's Strategy & Corporate Finance Practice in Pharmaceuticals & Medical Products. In her tenure at the company, she advised clients on a range of areas including new growth sectors, capital allocation, and mergers and acquisitions. Ruth holds a Licentiate in Law from University of Ghent, Belgium and a LL.M. from New York University.

Rebecca Port has served as Chief People Officer of 10x Genomics since 2021 and brings over 20 years of experience in building and scaling global teams across a range of industries. Rebecca was the Vice President of Human Resources at Netflix where she supported the company’s rapidly growing finance and operations groups, and was Managing Director of Human Resources at Standard Chartered Bank where she held a number of leadership roles across various groups in Europe and Asia. She worked with Allergan pharmaceuticals in Singapore, and has been a lecturer at City University in the United Kingdom. Rebecca holds a Ph.D in Psychology from the University of Sheffield, United Kingdom.

Serge Saxonov is the founder and chief executive officer of 10X Genomics. Prior to that, he was the vice president for applications at QuantaLife. Saxonov holds a PhD in biomedical informatics from Stanford University. He has also studied applied mathematics at Harvard University. Saxonov lives in San Francisco, California, United States.

Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. Prior to 10x Genomics, Hindson was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad in 2011. From 2002 to 2008, he served in various positions of increasing responsibility at Lawrence Livermore National Laboratory, in the Chemical and Biological Weapons Non-proliferation Program. He has published extensively in his field and holds many patents for assays and instrumentation. Hindson earned his BSc in Chemistry in 1998 and his PhD in Chemistry in 2001 from Deakin University, Australia.

Serge Saxonov is the founder and chief executive officer of 10X Genomics. Prior to that, he was the vice president for applications at QuantaLife. Saxonov holds a PhD in biomedical informatics from Stanford University. He has also studied applied mathematics at Harvard University. Saxonov lives in San Francisco, California, United States.

Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. Prior to 10x Genomics, Hindson was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad in 2011. From 2002 to 2008, he served in various positions of increasing responsibility at Lawrence Livermore National Laboratory, in the Chemical and Biological Weapons Non-proliferation Program. He has published extensively in his field and holds many patents for assays and instrumentation. Hindson earned his BSc in Chemistry in 1998 and his PhD in Chemistry in 2001 from Deakin University, Australia.